AMENDED AND RESTATED CHANGE OF CONTROL/SEVERANCE AGREEMENTChange of Control/Severance Agreement • February 3rd, 2017 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
This AMENDED AND RESTATED CHANGE OF CONTROL/SEVERANCE AGREEMENT (this “Agreement”), dated as of January 31, 2017 is entered into by and between PAREXEL International Corporation (together with all subsidiaries or affiliates hereinafter referred to as the “Company”) and Mark A. Goldberg (the “Executive”).
